SVFC...good news The US Food and Drug Administration (FDA) today approved Movantik (naloxegol), an oral peripherally acting mu-opioid receptor antagonist, for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain. See more at: http://www.hcplive.com/articles/FDA-Approves-Movantik-for-the-Treatment-of-Opioid-induced-Constipation?sao=31&utm_source=outBrain&utm_medium=HCPLive&utm_campaign=Pain%20Management#sthash.AV73L7jy.dpuf http://www.hcplive.com/articles/FDA-Approves-Movantik-for-the-Treatment-of-Opioid-induced-Constipation?sao=31&utm_source=outBrain&utm_medium=HCPLive&utm_campaign=Pain%20Management